Possible mechanisms of hypotension produced 70% alcoholic extract of Terminalia arjuna (L.) in anaesthetized dogs
© Nammi et al; licensee BioMed Central Ltd. 2003
Received: 15 March 2003
Accepted: 16 October 2003
Published: 16 October 2003
The bark of Terminalia arjuna L. (Combretaceae) is used in Ayurveda since ancient times for the treatment of cardiac disorders. Previous laboratory investigations have demonstrated the use of the bark in cardiovascular complications. The present study was aimed to find the effect of 70% alcoholic extract of Terminalia arjuna on anaesthetized dog blood pressure and probable site of action.
Six dogs were anaesthetized with intraperitoneal injection of thiopental sodium and the blood pressure of each dog (n = 6) was measured from the left common carotid artery connected to a mercury manometer on kymograph. The femoral vein was cannulated for administration of drug solutions. The extract of T. arjuna (dissolved in propylene glycol) in the dose range of 5 to 15 mg/kg were administered intravenously in a pilot study and the dose (6 mg/kg) which produced appreciable hypotension was selected for further studies.
Intravenous administration of T. arjuna produced dose-dependent hypotension in anaesthetized dogs. The hypotension produced by 6 mg/kg dose of the extract was blocked by propranolol but not by atropine or mepyramine maleate. This indicates that muscarinic or histaminergic mechanisms are not likely to be involved in the hypotension produced by the extract. The blockade by propranolol of the hypotension produced by T. arjuna indicates that the extract might contain active compound(s) possessing adrenergic ß2-receptor agonist action and/or that act directly on the heart muscle.
The results indicated the likely involvement of peripheral mechanism for hypotension produced by the 70% alcoholic extract of Terminalia arjuna and lends support for the claims of its traditional usage in cardiovascular disorders.
The bark of Terminalia arjuna L. (Combretaceae) has been widely used in Ayurvedic system of medicine for cardiac disorders since ancient times [1–3]. Extensive reviews on various aspects of T. arjuna have been published [4, 5]. Both experimental and clinical studies showed the beneficial effects of the bark in congestive heart failure [6–8] and in ischemic heart disease [9–14] and other cardiovascular complications [15–19]. The aqueous extract of T. arjuna showed contraction followed by relaxation on isolated rat thoracic aorta [15, 20]. Results from our laboratory demonstrated that 70% alcoholic extract of T. arjuna reduced the platelet count on chronic treatment to dogs . Singh et al. reported that aqueous solution of 70% alcoholic bark extract of T. arjuna produced dose-dependent decrease in heart rate and blood pressure in dogs, though the mechanism was not determined . In the present investigation, a systematic study was performed to find the probable mechanism of hypotension produced by 70% alcoholic extract of T. arjuna in thiopental anaesthetized dogs.
Plant material and extraction
The authenticated dried bark of Terminalia arjuna was purchased from the local herbal traders and was crushed to coarse powder 20–40 mesh size and then refluxed with 70% v/v alcohol for two hours using Soxhlett's apparatus. The extract was filtered and the filtrate was evaporated to dryness by rotary film evaporator. 1 g of bark extract represents 9.6 g of dried bark
Acetylcholine, histamine, isoprenaline and adrenaline were purchased from Sigma-Aldrich, St. Louis, USA. Other drugs used were mepyramine maleate (H. Jules & Co., Nagpur, India), propranolol (Imperial Chemical Industries, India), heparin sodium (Biological Evans Ltd., Hyderabad, India), trisodium citrate (SD Fine Chemicals, Boisar, India), thiopental and atropine sulphate (The Central Drug House, Mumbai, India).
Eight dogs of either sex weighing between 10 – 15 kg supplied by Visakhapatnam Municipal Corporation were used in the study. The animal experiments conducted in the research work were approved by the Institutional Animal Ethics Committee and by the government regulatory body for animal research (Regd. No. 516/01/A/CPCSEA). Thiopental sodium was administered intraperitoneally at a dose of 40 mg/kg body weight to anaesthetize the dogs. The femoral vein was cannulated for administration of subsequent doses of anaesthetic (if required) and drug solutions.
Recording of blood pressure
Haemodynamic setup was used to record the blood pressure of anaesthetized dog. The blood pressure of each animal was recorded from left common carotid artery connected to a mercury manometer on kymograph paper.
The normal blood pressure of dogs was recorded after stabilization for 30 minutes. The different doses 5, 6, 8, 10 and 15 mg/kg body weight of 70% alcoholic extract of T. arjuna were administered to all the animals (n = 6) while the dose 20 mg/kg body weight was studied in only 2 animals. The 6 mg/kg body weight dose of the extract which produced appreciable blood pressure lowering activity was used further to determine the change in its blood pressure response before and after administration of atropine (1 mg), mepyramine maleate (20 µg) and propranolol (30 µg).
Influence of atropine, mepyramine and propranolol on the hypotensive response of T. arjuna in dogs.
Dose (n = 6)
Atropine (1 mg)
Mepyramine (20 µg)
Propranolol (30 µg)
20 mg/kg(n = 2)
The hypotension produced by 6 mg/kg body weight dose of the extract was not blocked by atropine which could block the response of selected dose of acetylcholine indicating that the muscarinic mechanism was not involved. Studies with mepyramine maleate indicate that histaminergic mechanism was also not involved in the hypotension produced by the extract. Studies with propranolol which blocked the hypotensive response of the extract indicated that it may contain compounds having adrenergic ß-receptor agonist action. Even though propranolol is a non-specific ß-blocker, it is clear that the compounds present in the extract might be adrenergic ß2-agonists, since adrenergic ß2-receptor stimulation produces hypotension. Moreover, with the limitations of our study, one cannot completely ruled out the possibility that the observed hypotensive responsive could also be due to the effect of T. arjuna directly on the heart there by reducing the cardiac load. Earlier, it was reported that aqueous soluble fraction of 70% alcoholic extract (dried) of T. arjuna produced dose-dependent hypotension and decrease in heart rate  and were attributed to principles of the extract acting centrally. Our studies with 70% alcoholic extract dissolved in propylene glycol indicate the likely presence of compounds acting peripherally through adrenergic ß2-receptor mechanism and/or by direct action on the cardiac muscle. Mallikarjuna and co-workers  studied the influence of aqueous extract of T. arjuna on isolated rat thoracic aorta and found contraction followed by relaxant effect. It was felt that the vasorelaxant effect of T. arjuna extract could contribute to the reported decrease in blood pressure in anaesthetized dogs as observed by Singh et al . The same experiment on isolated vascular smooth muscle lends support for our observation that the hypotension could be of peripheral origin. However, Mallikarjuna and co-workers indicated that the vasorelaxant effect of the extract was not blocked by propranolol. The possible reason for this variable effect could be due to the difference in the active principles present in different types of extracts used. This indicates that the 70% alcoholic extract might contain compounds to a higher degree whose activity was blocked by propranolol while the activity produced by the constituents of aqueous extract were not blocked by propranolol. Further investigations are needed on the isolates of Terminalia arjuna to study their cardiovascular effects in order to explain more in detail of the observed results.
The present results indicate that the 70% alcoholic extract of Terminalia arjuna produced hypotension of peripheral origin and support the claims of its traditional usage as cardiovascular medicine. The observed effect could be due to adrenergic ß2-receptor agonistic and/or direct action on the heart. Detailed studies on the active constituents are needed which might provide new insights in cardiovascular drugs.
- Nadkarni AK:Terminalia arjuna. In: Indian Materia Medica. Edited by: Nadkarni AK. 1976, Mumbai, India, Popular Prakashan (Pvt) Ltd, I: 1199-Google Scholar
- Kirtikar KR, Basu BD:Terminalia arjuna.In: Indian Medicinal Plants. Edited by: Kirtikar KR, Basu BD. 1935, Allahabad, India, Lalit Mohan Basu Publications, II: 1023-1028. 2,Google Scholar
- Mukerji B: Arjuna. In: The Indian Pharmaceutical Codex. Edited by: Mukerji B. 1953, New Delhi, India, Council of Scientific and Industrial Research, I: 23-24.Google Scholar
- Dwivedi S, Udupa N: Terminalia arjuna: Pharmacognosy, Phytochemistry, Pharmacology and clinical use. A review. Fitoterapia. 1989, 60: 413-420.Google Scholar
- Kumar DS, Prabhakar YS: On the ethnomedical significance of the Arjun tree. J Ethnopharmacol. 1987, 20: 173-190. 10.1016/0378-8741(87)90086-9.View ArticlePubMedGoogle Scholar
- Colabawalla HM: An evaluation of the cardiotonic and other properties of Terminalia arjuna. Ind Heart J. 1951, 3: 205-230.Google Scholar
- Bharani A, Ganguly A, Bhargava KD: Salutary effect of Terminalia arjuna in patients with severe refractory heart failure. Int J Cardiol. 1995, 49: 191-199. 10.1016/0167-5273(95)02320-V.View ArticlePubMedGoogle Scholar
- Dwivedi S, Jauhari R, Varshney A: Terminalia arjuna – the cardiovascular friendly plant. Atherosclerosis. 1997, 134: 47-10.1016/S0021-9150(97)88322-0.View ArticleGoogle Scholar
- Jain V, Poonia A, Agarwal RP, Panwar RB, Kochar DK, Misra SN: Effect of Terminalia arjuna in patients of angina pectoris. Ind Med Gaz. 1992, 36: 56-59.Google Scholar
- Dwivedi S, Agarwal MP: Antianginal and cardioprotective effects of Terminalia arjuna, and indigenous drug in coronary heart disease. J Assoc Physi Ind. 1994, 42: 287-289.Google Scholar
- Dwivedi S, Gupta D: Efficiency of Terminalia arjuna in chronic stable angina. Ind Heart J. 2002, 54: 441-Google Scholar
- Bharani A, Ganguli A, Mathur LK, Jamra Y, Raman PG: Efficiency of Terminalia arjuna in chronic stable angina: a double-blind, placebo-controlled, cross over study comparing Terminalia arjuna with isosorbide mononitrate. Ind Heart J. 2002, 54: 170-175.Google Scholar
- Sumitra M, Manikandam P, Kumar DA, Arutselvam N, Balakrishna K, Manohar BM: Experimental myocardial necrosis in rats: role of arjunolic acid on platelet aggregation, coagulation and antioxidant status. Mol Cell Biochem. 2001, 224: 135-142. 10.1023/A:1011927812753.View ArticlePubMedGoogle Scholar
- Dwivedi S, Jauhari R: Beneficial effects of Terminalia arjuna in coronary artery disease. Ind Heart J. 1997, 49: 507-510.Google Scholar
- Tripathi YB: Terminalia arjuna extract modulates the contraction of rat aorta induced by KCl and norepinephrine. Phytother Res. 1993, 7: 320-322.View ArticleGoogle Scholar
- Vaidya AB: Terminalia arjuna in cardiovascular therapy. J Assoc Physi Ind. 1994, 42: 281-282.Google Scholar
- Gauthaman K, Maulik M, Kumari R, Manchanda SC, Dunda AK, Maulik SK: Effect of chronic treatment with bark of Terminalia arjuna : a study on the isolated ischemic reperfused rat heart. J Ethnopharmacol. 2001, 75: 197-201. 10.1016/S0378-8741(01)00183-0.View ArticlePubMedGoogle Scholar
- Miller AL: Botanical influences on cardiovascular diseases. Alt Med Rev. 1998, 3: 422-431.Google Scholar
- Shaila HP, Udupa SL, Udupa AL: Hypolipidemic activity of three indigeneous drugs in experimentally induced atherosclerosis. Int J Cardiol. 1998, 67: 119-124. 10.1016/S0167-5273(98)00281-2.View ArticlePubMedGoogle Scholar
- Mallikarjuna K, Thomas JF, Kane KA: Phytother Res. 1995, 9: 575-578.View ArticleGoogle Scholar
- Satyanarayana S, Srinivas N, Subrahmanya Kumar NV: Studies on the effect of 70% alcoholic extract of Terminalia arjuna on the hematology of dog. Ind Drugs. 1999, 36: 198-199.Google Scholar
- Singh N, Kapur KK, Singh SP, Shankar K, Sinha JN, Kohli RD: Mechanism of cardiovascular action of Terminalia arjuna. Planta Med. 1982, 45: 102-104.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6882/3/5/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.